Ian Mills
Chief Medical Officer
Sudo Bio
Sudo Bio provides a cloud‑based platform that automates the integration, cleaning, normalization, and statistical analysis of multi‑omics datasets, allowing researchers and clinicians to extract actionable insights without deep bioinformatics expertise.
- Data & Analytics
- Biotechnology
Updated 5 months ago
Funding
Raised to date
$30MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
Researchers and clinicians often lack rapid, cost-effective tools to analyze complex biological data, slowing discovery and diagnostic processes.
Solution
Sudo Bio offers a cloud-based platform that streamlines the integration, processing, and visualization of multi-omics datasets. The service automates data cleaning, normalization, and statistical analysis using scalable compute resources, enabling users to generate actionable insights without extensive bioinformatics expertise. Results are presented through interactive dashboards that support collaborative review and exportable reports, facilitating faster hypothesis testing and clinical decision-making.
Target Audience
Primary users are academic research labs, biotech companies, and healthcare institutions that need to analyze high-throughput biological data efficiently.
Features
- Automated pipelines for genomics, transcriptomics, proteomics, and metabolomics data preprocessing
- Scalable cloud infrastructure that handles large datasets with parallel processing
- Interactive visualization tools for pathway analysis, heatmaps, and network graphs
- Collaboration workspace allowing multiple users to share projects and annotate results in real time
- Export options for standard formats (CSV, JSON, PDF) and API access for integration with existing LIMS or EHR systems